T o survive tough times, cells sometimes resort to a form of self-cannibalism called autophagy. But as Hashimoto et al. reveal, autophagy can have a down side, destroying the pancreas by prematurely activating a digestive enzyme. In autophagy, a vesicle swallows a portion of cytoplasm and ferries it to the lysosome for digestion. The process is often benefi cial, allowing hungry cells to recycle molecules, for example. However, the researchers previously discovered that in mice with pancreatitis the level of autophagy in pancreatic cells surges. Pancreatitis occurs when the enzyme trypsin dissolves cells from within. Normally, pancreatic cells fashion and discharge an inactive form of trypsin called trypsinogen, which remains inert until it reaches the small intestine. But if trypsinogen converts to trypsin before its release, it can damage or kill a pancreatic cell. Hashimoto et al. tested whether autophagy promotes this early activation by delivering trypsinogen to the lysosome, where enzymes turn it on.
The researchers gave mice injections of the compound cerulein, which spurs pancreatitis. Control animals suffered severe damage to the organ, which harbored numerous deteriorating cells. But rodents that lack a gene necessary for autophagy displayed almost no symptoms. To determine whether autophagy promotes trypsinogen activation, the team dosed pancreatic cells from both types of mice with cerulein. Cells from the autophagy-impaired animals carried much less activated trypsinogen than did cells from controls.
In rodents capable of autophagy, cerulein injections triggered much higher levels of trypsin activity in pancreatic tissue than did shots of saline, confi rming that autophagy switches on the enzyme. The study is the fi rst to reveal that autophagy can initiate a disease. The next step, the researchers say, is determining what triggers pancreatic cells to start eating themselves. T wo enzymes that help manufacture amyloid β, the protein that accumulates in the brain in Alzheimer's disease, also take on another job. As Green et al. report, the enzymes, known as presenilins, help set calcium levels inside cells by activating a pump protein.
Presenilins partner with other proteins to create the enzyme γ-secretase, which helps snip amyloid β into shape. Faulty presenilins trigger a rare, earlyonset variant of Alzheimer's disease (AD) that strikes patients who are under 65 yr old. Presenilins might also help dictate how much calcium enters and exits the ER, which serves as the cell's storehouse for the ion. For instance, ER calcium release skyrockets in cells from patients with early onset AD. And in cells lacking one of the presenilins, the ER contains less calcium than normal. These results suggest that the presenilins help regulate SERCA, the protein that pumps calcium into storage.
To test that possibility, Green et al.
eliminated both presenilins from cells and found that their cytoplasmic calcium levels were higher than normal. The scientists also measured how rapidly frog eggs shuttled a controlled infl ux of calcium ions into the ER. Engineering the eggs to manufacture presenilins, which they don't normally make, accelerated calcium pumping into the ER. The location of presenilins and SERCA refl ects their close relationship, the team found. Presenilins not only settle alongside SERCA in the ER, they attach to the pump protein. Green et al. also discovered a link between amyloid β and SERCA: increased SERCA activity translated into higher amyloid β production. SERCA might exert this effect by prodding γ-secretase, the team concludes.
The results show that along with forming part of the protein-slicing γ-secretase complex, presenilins are crucial for regulating intracellular calcium homeostasis. Both functions allow the enzymes to exert control over amyloid β formation. Presenilin (red) and SERCA (green) cozy up in this fi broblast.
Pancreatic tissue from a control mouse shows damage from pancreatitis (top), but tissue from a mouse that can't instigate autophagy is healthy (bottom).
